{"id":464401,"date":"2021-03-24T11:58:14","date_gmt":"2021-03-24T15:58:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=464401"},"modified":"2021-03-24T11:58:14","modified_gmt":"2021-03-24T15:58:14","slug":"blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/","title":{"rendered":"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  24, 2021  (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of bluebird bio, Inc. (NASDAQ:BLUE) between May 11, 2020 and November 4, 2020, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>To join the class action, go to\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zEWN9lC0f8ik6u6ciOEW1tY0i2bA0oqWQ7O9tzt9x12mFj9VoG3BHNLK3sTU16rTyFZsuidSoWwOqRSVY9pw-d55t17Ehurl_BmfSlEhYIf_xaUMixUDxU5uZnOhNs7S7GR1HA_TPPKK_gl-P0t7T7DkCdofMhlVFIN29kYGkBKB6NpM1FMxwKePB87Ao4hq_A1E4mXJsOJLpLiu3Lf2EyCq03ALckPYk_znBt3dOW8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586<\/a> or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NTT1aiD57PrRgZGrCMkVHvisV77nsiGBrowudb2G_5RIw_VJyvmwzA1WJfb74sxXBq9jnfulE4EwgHohn280zRPn0iwtVrhJLy3H774m-oA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a>\u00a0for information on the class action.<\/p>\n<p>\u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zEWN9lC0f8ik6u6ciOEW1tY0i2bA0oqWQ7O9tzt9x12mFj9VoG3BHNLK3sTU16rTyFZsuidSoWwOqRSVY9pw-d55t17Ehurl_BmfSlEhYIdrzYshPAphhKeNK69qHpelYuslQ-hvVM1X6FW3IL8dOz3_EiAGBCBzuU7Fv1AYUm6LkqEzuU4QPhc6E012NFpnRSzsfuEDB_h0eXXCG1S9IO2fA-rZaK74rNp_2bALFRY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586<\/a><\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 13, 2021 DEADLINE.<\/strong>\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0<\/p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that- data supporting bluebird\u2019s U.S. Biologics Licensing Application (\u201cBLA\u201d) submission for LentiGlobin for sickle cell disease (\u201cSCD\u201d) was insufficient to demonstrate drug product comparability; defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the Company\u2019s BLA submission schedule for LentiGlobin for SCD, particularly with respect to manufacturing; as a result of all the foregoing, it was foreseeable that the Company would not submit the BLA for LentiGlobin for SCD in the second half of 2021; and as a result, the Company\u2019s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n<p>Lead plaintiff status is not required to seek compensation.\u00a0 You may retain counsel of your choice.\u00a0 You may remain an absent class member and take no action at this time.<\/p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Zhang Investor Law P.C.<br \/>99 Wall Street, Suite 232<br \/>New York, New York 10005<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NTT1aiD57PrRgZGrCMkVHvisV77nsiGBrowudb2G_5RSboq-H7nY_Rir4c4Y3LVxmJX3eVsUD6vkPVQO6cZZZn-p0x8ICBqXG91VYTERm4E=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a><br \/>tel: (800) 991-3756<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/31906354-2d55-4d3f-8c94-5c09f1b5ef4d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of bluebird bio, Inc. (NASDAQ:BLUE) between May 11, 2020 and November 4, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to\u00a0http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586 If you wish to serve as lead plaintiff, you must move the Court before the April 13, 2021 DEADLINE.\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that- data &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-464401","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of bluebird bio, Inc. (NASDAQ:BLUE) between May 11, 2020 and November 4, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to\u00a0http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586 If you wish to serve as lead plaintiff, you must move the Court before the April 13, 2021 DEADLINE.\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that- data &hellip; Continue reading &quot;BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-24T15:58:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE\",\"datePublished\":\"2021-03-24T15:58:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/\"},\"wordCount\":328,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/\",\"name\":\"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==\",\"datePublished\":\"2021-03-24T15:58:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/","og_locale":"en_US","og_type":"article","og_title":"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE - Market Newsdesk","og_description":"NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of bluebird bio, Inc. (NASDAQ:BLUE) between May 11, 2020 and November 4, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to\u00a0http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=bluebird-bio-inc&amp;id=2586 If you wish to serve as lead plaintiff, you must move the Court before the April 13, 2021 DEADLINE.\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that- data &hellip; Continue reading \"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-24T15:58:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE","datePublished":"2021-03-24T15:58:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/"},"wordCount":328,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/","name":"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==","datePublished":"2021-03-24T15:58:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTgxNSM0MDkwMDM5IzUwMDA1MzY0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blue-deadline-alert-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-bluebird-bio-inc-blue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BLUE DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against\u00a0bluebird bio, Inc. \u2013 BLUE"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=464401"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464401\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=464401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=464401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=464401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}